Methods and compositions for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies

Details for Australian Patent Application No. 2008323701 (hide)

Owner GENENTECH, INC.

Inventors Burington, Bruce; Dornan, David

Agent Griffith Hack

Pub. Number AU-A-2008323701

PCT Pub. Number WO2009/062125

Priority 60/986,277 07.11.07 US

Filing date 7 November 2008

Wipo publication date 14 May 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/062125 Priority application(s): WO2009/062125

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323703-Mult i layered SOFC device on ceramic support structure

2008323700-Interface for wagering game environments